- Home
- ARMN vs TLRY Comparison
ARMN vs TLRY Comparison
Compare ARMN & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARMN
- TLRY
- Stock Information
- Founded
- ARMN 1992
- TLRY N/A
- Country
- ARMN Canada
- TLRY Canada
- Employees
- ARMN N/A
- TLRY N/A
- Industry
- ARMN
- TLRY Medicinal Chemicals and Botanical Products
- Sector
- ARMN
- TLRY Health Care
- Exchange
- ARMN Nasdaq
- TLRY Nasdaq
- Market Cap
- ARMN 2.0B
- TLRY 1.8B
- IPO Year
- ARMN N/A
- TLRY 2018
- Fundamental
- Price
- ARMN $10.79
- TLRY $1.72
- Analyst Decision
- ARMN Strong Buy
- TLRY Buy
- Analyst Count
- ARMN 1
- TLRY 4
- Target Price
- ARMN $17.00
- TLRY $1.58
- AVG Volume (30 Days)
- ARMN 2.1M
- TLRY 83.2M
- Earning Date
- ARMN 11-11-2025
- TLRY 10-09-2025
- Dividend Yield
- ARMN N/A
- TLRY N/A
- EPS Growth
- ARMN N/A
- TLRY N/A
- EPS
- ARMN 0.02
- TLRY N/A
- Revenue
- ARMN $646,783,000.00
- TLRY $821,309,000.00
- Revenue This Year
- ARMN $49.45
- TLRY $6.66
- Revenue Next Year
- ARMN $13.00
- TLRY $4.75
- P/E Ratio
- ARMN $413.00
- TLRY N/A
- Revenue Growth
- ARMN 38.72
- TLRY 4.10
- 52 Week Low
- ARMN $3.29
- TLRY $0.35
- 52 Week High
- ARMN $10.87
- TLRY $1.88
- Technical
- Relative Strength Index (RSI)
- ARMN 74.04
- TLRY 63.12
- Support Level
- ARMN $9.67
- TLRY $1.51
- Resistance Level
- ARMN $10.86
- TLRY $1.88
- Average True Range (ATR)
- ARMN 0.40
- TLRY 0.15
- MACD
- ARMN 0.04
- TLRY 0.02
- Stochastic Oscillator
- ARMN 99.24
- TLRY 70.95
About ARMN Aris Mining Corporation
Aris Mining Corp is engaged in the acquisition, exploration, development, and operation of gold properties in Colombia, Guyana, and Canada. It owns and operates its Segovia Operations, Soto Norte Project and Marmato Mine in Colombia, the Toroparu Project in Guyana, and the Juby Project in Ontario, Canada. The company generates revenue from the sale of gold and silver.
About TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mostly from alcohol.